您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定

[Progress in research of vaccination for patients with cancer].

摘要:

Due to the tumor malignancy or immunosuppressive treatment, patients with cancer in general are more susceptible to vaccine-preventable infections. The types, timing, dose of vaccination or even the immunization program for them may differ from those for the normal persons. At present, it is recommended to use inactivated vaccines for patients with cancer rather than attenuated live vaccines, Vaccinations should be avoided during immunosuppressive therapy; patients with cancer should receive double dosage of hepatitis B vaccines and two doses of inactivated influenza vaccines yearly. This paper summarizes the progress in clinical trials of vaccination for cancer patients in foreign countries, and provide reference for the development and implementation of vaccination strategy for cancer patients in China.

更多
作者: S Y, Jia [1] ; J X, Li [2] ; F C, Zhu [3]
作者单位: School of Public Health, Nanjing Medical University, Nanjing 211166, China. [1] Department of Vaccine Clinical Evaluation, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China. [2] School of Public Health, Nanjing Medical University, Nanjing 211166, China; Department of Vaccine Clinical Evaluation, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing 210009, China. [3]
期刊:
《Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi》 2018年39卷1期98-101页
DOI: 10.3760/cma.j.issn.0254-6450.2018.01.021
发布时间: 2018-04-17
翻译满意度评价:
提交
  • 浏览:1

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!